Catherine Barbey - Biogen Inc | 人才画像

基本信息

浏览量：26

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 51 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Editorial: Cutaneous lupus erythematosus landscape: pathophysiology, unmet needs, and related challenges in clinical practice. What is on the horizon

Joseph F. Merola,Filippa Nyberg,Nathalie Franchimont,Catherine Barbey,Victoria P. Werth

FRONTIERS IN MEDICINE（2024）

引用0浏览0WOS引用

1006 Evaluation of intra-renal plasmacytoid dendritic cells in active lupus nephritis

Brad H Rovin,Samir V Parikh,Catherine Barbey,Taylor L Reynolds, Su Jing Chan, Luke Jandreski, Kyle Ferber

Lupus Science and Medicineno. Suppl 2 (2024)

引用0浏览0引用

Evaluation of Intrarenal Plasmacytoid Dendritic Cells in Active Lupus Nephritis

Brad H. Rovin,Samir V. Parikh, Su Jing Chan, Luke Jandreski, Kyle Ferber,Catherine Barbey,Taylor L. Reynolds

Journal of the American Society of Nephrologyno. 11S (2023): 240-241

引用0浏览0引用

Litifilimab modulates Type I interferon biomarkers in patients with cutaneous lupus erythematosus: Result of the LILAC Part B Phase 2 study

V. Werth,R. Furie, J. Merola, E. Milliman, K. Ferber, F. Casey,R. Brown, D. Raitcheva, J. Zoghbi, D. Graham, G. Kong, Y. Lahoud,

Journal of Investigative Dermatologyno. 11 (2023): S363-S363

引用0浏览0引用

SRI-4 and BICLA: How Well Do They Agree Across Trials of Active Systemic Lupus Erythematosus

Alfredo Aguirre, Mimi Kim,Kosalaram Goteti, Ying Li,Amy Kao, Nathalie Franchimont, George Kong,Catherine Barbey,Qing Zuraw,Robert Gordon, David Manner,Maria Silk,

ARTHRITIS & RHEUMATOLOGY (2022): 4049-4052

引用0浏览0引用

Efficacy of BIIB059 on Joint and Skin Manifestations in Participants with Systemic Lupus Erythematosus (SLE): Exploratory Analyses of the Phase 2, Randomized, Double-Blind, Placebo-Controlled LILAC Study (Part A)

Richard Furie, Ronald van Vollenhoven,Victoria Werth,Kenneth Kalunian,Sandra Navarra,Juanita Romero-Diaz, Ting Wang,Cristina Musselli,Catherine Barbey,Nathalie Franchimont

ARTHRITIS & RHEUMATOLOGY (2022): 720-723

引用0浏览0引用

Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus

Victoria P Werth, Richard A Furie,Juanita Romero-Diaz,Sandra Navarra,Kenneth Kalunian, Ronald F van Vollenhoven,Filippa Nyberg,Benjamin H Kaffenberger,Saira Z Sheikh,Goran Radunovic,Xiaobi Huang,George Clark,

The New England journal of medicineno. 4 (2022): 321-331

引用30浏览0WOS引用

Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus

Richard A Furie, Ronald F van Vollenhoven,Kenneth Kalunian,Sandra Navarra,Juanita Romero-Diaz,Victoria P Werth,Xiaobi Huang,George Clark,Hua Carroll,Adam Meyers,Cristina Musselli,Catherine Barbey,

N Engl J Med（2022）

引用24浏览0WOS引用

Improvements in Skin Manifestations with BIIB059 Measured by CLASI in Participants with Cutaneous Lupus Erythematosus (CLE): Exploratory Analyses of the Phase 2, Randomized, Double-Blind, Placebo-Controlled LILAC Study (Part B)

Victoria Werth, Ronald van Vollenhoven, Richard Furie,Filippa Nyberg,Kenneth Kalunian,Sandra Navarra,Juanita Romero-Diaz, Wenbin Zhu,Catherine Barbey,Cristina Musselli,Nathalie Franchimont

ARTHRITIS & RHEUMATOLOGY（2022）

引用0浏览0引用

Towards a Novel Clinician-Reported Outcome Measure for SLE - Outcomes of an International Consensus Process

Kathryn Connelly,Laura Eades,Rachel Koelmeyer,Darshini Ayton,Vera Golder,Rangi Kandane-Rathnayake, Kate Gregory-Wong,Hussein Al-Mossawi,Jeanette Andersen,Cynthia Aranow, Laurent Arnaud,Anca Askanase,

ARTHRITIS & RHEUMATOLOGY（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn